[Double-blind, placebo-controlled trial of propranolol vs celiprolol in stable effort angina: antianginal efficacy and side effects ].


A new cardioselective betablocker, celiprolol (C) in a dosage of 100 mg t.i.d. and propranolol (P) 40 mg t.i.d. were compared in 21 patients with angiographically documented obstructive coronary artery disease (stenosis of 75% or more in at least one vessel) and stable angina in a double-blind, placebo-controlled trial. C led to a significant reduction of… (More)